Yasmin, Yaz Blood Clot Concerns To Be Reviewed by FDA Panel

A federally-funded study suggests that side effects of Yaz and Yasmin may carry a 150% increased risk of blood clots over other forms of birth control, and federal regulators have called for a panel of experts to review the safety of the popular birth control pills.

The FDA announced on Monday that it will hold a joint meeting of its Reproductive Health Drugs Advisory Committee and its Drug Safety and Risk Management Advisory Committee on December 8, 2011, to discuss the risks and benefits of Yaz, Yasmin and other oral birth control pills using the progestin drospirenone.

The meeting was called after the FDA’s own Yaz safety review failed to reach a conclusion, but found enough evidence of health risks to be concerned. That review is ongoing.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

FDA reviewers examined two studies from this year that looked at the side effects of drospirenone-based birth control, and the regulatory agency is also looking at the preliminary results from a study the FDA itself funded. That study suggests that the risk of blood clots with Yaz and Yasmin may be increased 1.5 times over other pills. The FDA has analyzed six studies in all, which the agency said often give conflicting information.

The advisory committees will meet and look at the evidence and then make recommendations to the FDA about any regulatory steps that may be necessary to protect the consumers from the potential risk of blood clots. While the recommendations are not binding, the FDA often bases its decisions off its advisory committees’ advice.

Drospirenone is a newer type of progestin that is used in combination oral contraceptives that also include estrogen. It was originally introduced by Berlex Laboratories in Yasmin. Once Berlex was acquired by Bayer Healthcare an updated version of Yasmin was introduced called Yaz. More recently, Bayer introduced a third version, marketed as Beyaz, which includes a folate supplement. Generic versions of Yaz and Yasmin are also now available from other manufacturers.

Bayer currently faces thousands of Yaz lawsuits, Yasmin lawsuits and Beyaz lawsuits, which allege that the drug maker has failed to adequately warn about the increased risk of health problems associated with the birth control pills.

The complaints have been filed on behalf of women who have suffered heart attacks, strokes, pulmonary embolism, deep vein thrombosis and other serious blood clot-related injuries, which they allege may have been prevented if more adequate information about the Yasmin and Yaz blood clot risk had been provided.

Image Credit: |

1 Comments

  • amraSeptember 28, 2011 at 10:41 pm

    It's about time the FDA recognized the increased risk of Yaz. My 9 day stay in the hospital after taking YAZ for only 60 days has changed my healthy life to one of contant pain and accomodating one leg that now receives very little circulating blood after clots so damaged i the veins collapsedt. I will also live with a metal filter in my Inferior Vena Cava to prevent the return of pulmonary emboli[Show More]It's about time the FDA recognized the increased risk of Yaz. My 9 day stay in the hospital after taking YAZ for only 60 days has changed my healthy life to one of contant pain and accomodating one leg that now receives very little circulating blood after clots so damaged i the veins collapsedt. I will also live with a metal filter in my Inferior Vena Cava to prevent the return of pulmonary embolism. And all because my OB-GYN prescripbed it for estrogen replacement at age 45. For the life of me I cannot understand why no one has developed, or even seen the need to develop, a test to determine whether one has a propensity for clotting prior to being prescribed to take this poison? And does anyone believe that Physicians really do a good job of warning patents about the potential dangers of YAZ? I've had more than one tell me they would not prescribe YAZ for their wife or daughter. Birth control accomplished by altering the body's chemical and physiological processing is a fools errand. And Bayer is complicit in the death of many of it's users and will admit so....albiet the small number of deaths and damaged users represents a controllable cost pending the success of pending lawsuits. So Silicone Breast Implant manufacturers paid out billions to women that couldn't prove a singular cause and effect while Bayer recognizes and even agrees that YAZ can cause blood clots but continues to market their product. Their strategy is obviously to run out the Lawsuit clock all the while setting aside a portion of every filled prescription to pay out a settlement somtime in the future. In the meantime an acceptable number of young women will either die or pay with being physically damaged for the rest of their lives. But just let one persons die from eating tainted beef and the country goes on "fast food lockdown" resulting in warnings both verbal and written if you order your burger anything other than medium or well done. Go figure! Confession: My husband helped me write these comments and I have engaged l Law Firm to sue Bayer on my behalf.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward
Gardasil Lawsuits Over Failure To Warn Doctors About HPV Vaccine Risks Cleared To Move Forward (Posted today)

A federal judge has cleared Gardasil lawsuits to move forward, after paring down plaintiffs' claims to those alleging Merck either failed to warn, or fraudulently concealed, the HPV vaccine's risks from the medical community.